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ABSTRACT 
Despite the ubiquitous role of ATP Binding Cassette (ABC) importers in nutrient uptake,  
only the E. coli maltose and vitamin B12 ABC transporters have been structurally 
characterized in multiple conformations relevant to the alternating access transport 
mechanism. To complement our previous structure determination of the E. coli MetNI 
methionine importer partner in the inward facing conformation (Kadaba et al. Science 321, 
250-253, 2008), we have explored conditions stabilizing the outward facing conformation. 
Using two variants, the Walker B E166Q mutation with ATP and EDTA to stabilize MetNI 
in the ATP-bound conformation, and the N229A variant of the binding protein MetQ to 
disrupt methionine binding as shown in this work, a high affinity MetNIQ complex was 
formed with a dissociation constant measured to be 27 nM. We then solved a 2.95 Å 
resolution crystal structure of the outward-facing conformation of the MetNI transporter, in 
complex with its binding protein, MetQ. The structure sheds light on how the C-regulatory 
domains regulate transport activity by rearrangement of a hydrogen bonding network 
between their interfaces in two different conformations. Structure of the substrate-free 
homologous MetQ from N. meningitides was also resolved using the N-to-A mutation 
(N238A). Superimposition of the substrate-bound, substrate-free (homologous model) MetQ 
and the binding protein MetQ in complex with its MetNI transporter (complexed MetQ) 
reveals unexpected structural features of the complexed MetQ, indicates a different substrate 
delivery mechanism for the MetNI transporter. These structural insights, coupled with 
thermodynamic binding constant and in vivo transport studies, support an unconventional 
transport mechanism for the Type-I methionine ABC importer. 
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CHAPTER 1: INTRODUCTION 
1.1. Introduction to ABC transporters and the E. coli methionine-ABC transporter 
ATP-Binding-Cassette (ABC) transporters compose one of the largest protein 
families and play a variety of physiological roles, including the transport of a diversity of 
substrates in all species from microbes to humans 1–3. In microorganisms, ABC transporters 
are crucial for nutrient uptake, the removal of toxins, and antibiotic resistance 1–3. In 
humans, many of the transporters are clinically relevant, such as the cystic fibrosis 
transmembrane conductance regulator (CFTR) in the development of cystic fibrosis, and 
the multidrug-resistance transporter, P-glycoprotein (Pgp), in cancer cell survival 1,4,5.  
While studies on eukaryotic ABC transporters are still underway, many 
fundamental principles of ABC transporters have been derived from structural and 
biochemical characterizations of their bacterial/archaeal homologs. About 5% of the E. coli 
genome has been classified as encoding ABC transporters (Blattner et al., 1997; Linton and 
Higgins, 1998, Rees, Johnson, & Lewinson, 2009). Our work focuses on the structural 
characterization of a high-affinity methionine-ABC transport system from Escherichia coli 
K-12. These proteins are highly conserved in bacteria 7, and are important for the infectivity 
and survival of several human pathogens (8–11; note: MetNI is misidentified in the first two 
references).  
1.2. Background 
ABC transporters consist of four domains: two transmembrane domains (TMDs) 
that form the translocation pathway, and two nucleotide-binding domains (NBDs) that use 
the energy from ATP binding and hydrolysis to fuel transport 1,2,6,12. ABC importers, 
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mostly found in prokaryotes, archaea, and plants, require additional domains, such as 
substrate-binding domains located in the periplasm of Gram-negative bacteria or tethered 
to the membrane in Gram-positive bacteria and archaea, to bind and deliver substrates to 
their cognate transporters (Ames et al., 1992; Wilkinson and Verschueren, 2003; Berntsson 
et al., 2010). 
In general, the ABC transporter cycle utilizes a mechanism called the alternating 
access model 13 that involves the interconversion of two distinct conformations: an inward-
facing and outward-facing conformation that opens the translocation pathway to the 
cytoplasm and periplasm, respectively.  
Despite numerous biochemical and structural characterization reports on ABC 
uptake systems 14–18, only two nutrient uptake systems, the maltose uptake system, 
MalFGK2, and the vitamin B12 uptake system, BtuCD, have been studied extensively 19,20. 
These models were built on the structural determinations of different conformations of 
MalFGK2 and BtuCD transporters during their transport cycles 16,19–22. Though both 
transporters share the same overall alternating access model, structures of these 
transporters in complex with their binding proteins have demonstrated differences in the 
details of their transport mechanisms. For example, studies by Oldham and colleagues 
highlight a unique pre-translocation intermediate conformation during the maltose 
transport cycle, where a liganded maltose-binding protein (MalE) first engages with an 
inward facing conformation of MalFGK2 19 (Fig 1.1b). Works by Korkhov and colleagues 
on the vitamin-B12 transporter identified a two-cytoplasmic-gate system that ensures the 
substrate specificity 21.  
  
3 
 
Figure 1.1. Proposed mechanistic models of the Type-I maltose transporter based on 
structural works (a) from Dr. Jue Chen’s group and biochemical works (b) from Dr. Frank 
Duong’s group. 
 
In this work, we focus on the structural characterizations of the Escherichia coli 
high-affinity methionine uptake system (Kadner, 1974), comprising the MetNI transporter 
and its cognate binding-protein, MetQ (Gál et al., 2002; Merlin et al., 2002). Like a typical 
ABC transporter, the MetNI transporter consists of four polypeptides: two copies of a trans-
membrane subunit (MetI), and two copies of a nucleotide-binding subunit (MetN) 23,24. 
Currently, only the inward facing conformation of the E. coli methionine-ABC transporter 
has been determined structurally (Kadaba et al., 2008; Johnson et al., 2012). 
Crystallographic structures of this transporter notably revealed an additional domain at the 
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C-terminus of the MetN subunit, termed the C-regulatory or C2 domain 18,24. This domain 
is involved in trans-inhibition 25, whereby binding of L-methionine to this domain stabilizes 
the inactive form of the MetN ATPase domain and the inward-facing conformation of 
MetNI (Kadaba et al., 2008; Johnson et al., 2012). 
1.3. Statement of problems 
Controversial proposed mechanistic models for Type-I ABC importers 
Equilibrium studies (Bao & Duong, 2013) on the prototypic type-I maltose 
importer, MalFGK2, contradict the mechanistic models inferred from structural 
information 16,19. Nanodisc-based equilibrium studies on the maltose uptake system favor 
a model in which the outward-facing-conformation of the transporter is triggered by ATP 
binding alone. This conformation then assembles with unliganded MalE to form a 
MalFGK2-E complex, to which maltose subsequently binds (Fig 1.1b) (Bao & Duong, 
2013) . This observation is different from what X-ray crystallographers have reported for 
the translocation intermediate state mentioned above, which suggested that the outward-
facing conformation is triggered by the binding of liganded MalE to the inward-facing 
conformation 19.  
Transinhibition, a distinct regulation feature, may indicate different mechanistic model for 
the methionine transporter 
Trans-inhibition, best characterized by studies on the E. coli MetNI and 
Methanosarcina acetivorans ModBC transporters 18,29,30, has not been observed in either 
the maltose or vitamin-B12 uptake systems. Therefore, current proposed mechanistic 
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models of the type-I maltose transporter are inadequate to fully explain the methionine 
uptake system.  
Little is known about how the binding protein grasps its substrate and how the transporter 
and its binding partner engage for substrate delivery 
Although structures of individual proteins of the methionine transport system, 
including the MetNI transporter and the MetQ binding protein, have been solved, little is 
known about how the binding protein engages and delivers the substrate to the MetNI 
transporter.  
1.4. Primary research questions 
Thus far only the inward-facing (IWF) conformation of MetNI has been solved, in 
a trapped, inhibited state (CY5 form) 18,24. To build a comprehensive mechanistic model 
for the MetNIQ transport system, we sought to find answers to the following questions: (1) 
How does the binding protein interact with its transporter? (2) How do the C-regulatory 
domains regulate the transport of methionine? (3) How does the binding protein bind or 
release its substrate? (4) What is the sequential order of interactions among the MetQ 
binding protein, the MetNI transporter, ATP, and methionine? And finally (5) what is the 
mechanistic model for the MetNI methionine transporter? 
1.5. Significance of study 
The structure of the methionine-ABC transporter in complex with its binding 
protein would address key questions, such as how the transporter and its binding protein 
work together to acquire methionine for bacteria, and how the transport is regulated by the 
C-regulatory domains. 
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A solid mechanistic transport model can be proposed by combining structural 
findings with biochemical and biophysical characterizations. This model can be applied to 
the study of other amino acid transporters, Type-I homodimeric ABC importers, and other 
transport systems ruled by trans-inhibition. 
Understanding the regulation of ABC transporters would also aid in the design of 
better antibiotics and anticancer drugs. 
1.6. Research Design 
(1) How does the binding protein interact with its transporter?  
We sought to determine the structure of the outward-facing conformation MetNI in 
complex with its binding partner, MetQ. We would first identify conditions under which 
the MetNI transporter forms a stable complex with the cognate periplasmic binding protein 
MetQ. We developed a qualitative method to observe the association of the MetNI 
transporter to MetQ, using gel filtration and BN PAGE. Furthermore, in collaboration with 
Dr. Qiwen Li, we measured the dissociation constants of MetNI to MetQ using Microscale 
Thermophorensis techniques. We then crystallized the MetNIQ complex and solved the 
structure of the complex to reveal the interaction between the MetNI transporter and its 
MetQ binding protein. 
(2) How does the C-regulatory domains regulate transport of methionine?  
To elucidate the mechanism that underlies transport regulation, we sought to 
characterize structural changes of the C-regulatory domains in two conformational states, 
IWF and OWF conformations, of the MetNI transporter. L-methionine was soaked into 
crystals of MetNI to see how it stabilizes the IWF conformation of MetNI. 
  
7 
(3) How does the binding protein bind or release its substrate?  
To elucidate how the binding protein MetQ binds methionine, we sought to 
determine the crystal structure of MetQ in its substrate-free form and compare it to the 
substrate-bound MetQ structure. A co-purifying methionine was observed in the crystal 
structures of the substrate-binding protein, MetQ 31. We developed an approach to use 
alanine-scanning mutagenesis to identify MetQ mutants that disrupt the binding of L-
methionine. This mutant would be used as a substrate-free form of MetQ for crystallization 
purposes. 
(4) What is the sequential order of interactions among the MetQ binding protein, the MetNI 
transporter, ATP, and methionine?  
To address the question of the sequential interaction between the binding protein, 
the transporter, and the substrate, we sought to observe the binding affinities (Kd) of the 
binding protein to its substrate and to its transporter. 
(5) What is the mechanistic model for the MetNI methionine transporter? 
To propose a mechanistic model for the MetNI methionine transporter, we 
biochemically characterized functions of the MetNI methionine transporter by in vivo 
transport assays. We then combined structural insights with thermodynamic binding 
constants determined from (4), along with kinetic transport constants, to propose an 
atomic-level mechanistic model for the MetNI methionine transporter. 
1.7. Outline of thesis 
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In Chapter 2, I present the work on stabilizing the complex of MetNIQ in solution. 
Preparation of the stable MetNIQ complex in solution was a key for determining its crystal 
structure mentioned in chapter 3. 
In Chapter 3, I present the crystal structure of the MetNIQ complex in a catalytic 
intermediate state. Combining structural information, enzyme kinetic, and equilibrium 
studies, I propose a mechanistic model for the methionine transporter. 
In Chapter 4, I summarize our results, answer relevant questions raised by the 
findings, and conclude with a discussion of the results. 
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CHAPTER 2 
THE CONTRIBUTION OF METHIONINE TO THE STABILITY OF THE 
ESCHERICHIA COLI METNIQ ABC TRANSPORTER - SUBSTRATE BINDING 
PROTEIN COMPLEX 
Published as Nguyen, P.T, Li, Q.W., Kadaba, N.S., Lai, J.Y., Yang J.G., Rees, D.C. “The 
contribution of methionine to the stability of the Escherichia coli MetNIQ ABC 
transporter-substrate binding protein complex.” Biol Chem. 396(9–10), 1127–34. (2015)      
2.1.  Introduction 
Many different transporters are encoded in the genomes of microorganisms to 
accommodate the diversity of molecules they need to acquire from the environment. For 
example, ~10% of the E. coli genome has been classified as participants in transport 
processes, of which approximately half are ATP-binding cassette (ABC) transporters 1,2. 
ABC transporters consist of four domains: two transmembrane domains (TMDs) that form 
the translocation pathway, and two nucleotide-binding domains (NBDs) that use the energy 
from ATP binding and hydrolysis to fuel transport (reviewed in (Ames et al., 1992; 
Higgins, 1992; Holland et al., 2003; Locher, 2008; Oldham et al., 2008; Rees et al., 2009)). 
The transport mechanism utilizes an alternating access model (Widdas, 1952; Jardetsky, 
1966) that involves the interconversion of two distinct conformations during the transport 
cycle, inward facing and outward facing, where the translocation pathway is open to the 
cytoplasm and periplasm, respectively. ABC importers, mostly found in prokaryotes, 
archaea and plants, require an additional component for transport, namely substrate-
binding proteins (SBP), located in the periplasm of Gram-negative bacteria or tethered to 
the membrane in Gram-positive bacteria and archaea, to bind and deliver substrates to their 
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cognate transporter (Ames et al., 1992; Wilkinson and Verschueren, 2003; Berntsson et al., 
2010). Structures of transporters in complex with their binding proteins (Hollenstein et al., 
2007; Hvorup et al., 2007; Oldham et al., 2007; Korkhov et al., 2012) have been 
instrumental in defining basic features of the transport cycle, including the two best 
structurally characterized ABC importers, the Type I maltose uptake system, MalFGK2 
(Oldham and Chen, 2011) and the Type II vitamin B12 uptake system, BtuCD (Korkhov et 
al., 2014). Despite the common nucleotide-dependent engine driving translocation, binding 
protein - transporter interactions can vary significantly, reflecting mechanistic diversity 
between various ABC importers (Lewinson et al., 2010). 
In this work, we focus on the Escherichia coli high affinity methionine uptake 
system (Kadner, 1974), comprising the MetNI transporter and its cognate binding-protein, 
MetQ (Gál et al., 2002; Merlin et al., 2002). Currently, only the inward facing 
conformational state of MetNI has been solved crystallographically (Kadaba et al., 2008; 
Johnson et al., 2012). To build a comprehensive model for MetNI transport, we sought to 
identify conditions under which a stable transporter-binding protein complex can form. A 
challenge in working with E. coli MetNI is that while methionine is the transported ligand, 
it also functions as an allosteric effector inhibiting methionine uptake at sufficiently high 
intracellular concentrations (Kadner, 1975). This phenomenon of transinhibition is 
mediated by methionine functioning as a noncompetitive inhibitor of ATPase activity 
(Yang and Rees, 2015) by binding to a cytoplasmic regulatory domain of the ABC subunit 
MetN to stabilize MetNI in an inward facing conformation incapable of hydrolyzing ATP 
(Kadaba et al., 2008; Johnson et al., 2012). Further complicating the analysis is the 
observation of a co-purifying methionine in crystal structures of methionine binding SBPs 
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(Deka et al., 2004; Williams et al., 2004; Yang et al., 2009; Yu et al., 2011), including the 
E. coli MetQ structure (Kadaba, 2008).  
Here we demonstrate that formation of a high affinity MetNIQ complex requires 
an ATP-bound state of MetNI and an unliganded form of MetQ. Preparation of this 
complex is facilitated by the identification of mutations in MetQ that abolish methionine 
binding. The effect of methionine on complex formation between ATP-stabilized MetNI 
and MetQ is quantitated by titrating fluorescently labeled MetQ with varying 
concentrations of MetNI. From these measurements, dissociation constants of 1100 ± 300 
and 27  ± 9 nM are found for methionine-bound and methionine free MetQ, respectively, 
establishing that ligand-free MetQ can form a stable complex with the ATP-bound form of 
MetNI. Our isolation of a stable MetNIQ complex is an essential step towards the 
crystallographic analysis of the outward facing conformation, a key intermediate in the 
uptake of methionine by this transporter. 
2.2. Results and discussion 
To better understand the mechanism of the methionine transport system, we sought 
to identify conditions under which the MetNI transporter forms a stable complex with the 
cognate periplasmic binding protein MetQ. Previous studies demonstrated that wild type 
MetNI and wild type MetQ interact weakly in the absence of nucleotide (Kd = 7.4 x 10-5 
M) and a stable complex under these conditions could not be detected by gel filtration 
chromatography (Lewinson et al., 2010). Based on studies of the maltose system (Chen et 
al., 2001), we hypothesized that the MetNI transporter binds MetQ with the highest affinity 
in an ATP-bound state. To maintain the ATP-bound state, an ATPase deficient form was 
generated by substitution of Glu 166 in the Walker B motif of MetN with Gln (E166Q), in 
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combination with the use of the chelator EDTA with ATP to remove the catalytically 
essential Mg2+. Mutation of the Walker B Glu is commonly used to inhibit hydrolysis, but 
not binding, of ATP by ABC transporters (Moody et al., 2002)
Figure 2.1. Detection of MetNIQ complex formation 
a. Gel filtration for detection of complex formation. Reactions of E166Q MetNI (40 µM) 
and MetQ at the indicated molar ratios in the presence of 1 mM ATP and 1 mM EDTA 
were injected onto a size exclusion column. The highest A280 eluate peak was analyzed by 
BN PAGE.  
b. BN PAGE of the highest peak from the schematic shown in A. Lane 1: E166Q MetNI 
alone, lanes 2 and 3: wild type MetQ added to E166Q MetNI at different ratios, 1:1.25 and 
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1:6 (MetNI: MetQ), lane 4: N229A MetQ added to E166Q MetNI at 1:1.25 (MetNI: MetQ) 
ratio.  
ATPase assays show that the E166Q mutation results in a 20-fold reduction in 
ATPase activity (data not shown). All subsequent experiments in this study were conducted 
using this mutant transporter, denoted E166Q MetNI, in the presence of saturating amounts 
of ATP+EDTA (1 mM ATP and 1 mM EDTA) to mimic the ATP-bound state. 
We first tested for complex formation by incubating E166Q MetNI with wild type 
MetQ and saturating amounts of ATP+EDTA at different ratios of transporter to binding 
protein. Mixtures of either 1:1.25 or 1:6 (MetNI: MetQ) were injected onto a gel filtration 
column (Fig 2.1a), and the peak fraction was analyzed by blue native PAGE (BN PAGE 
(Reisinger and Eichacker, 2006)) (Fig 2.1b) to evaluate the extent of complex formation. 
Despite an excess of MetQ, incomplete complex formation was observed in both cases (Fig 
2.1b., lanes 2 and 3), as established by the presence of two bands on BN PAGE, the upper 
one corresponding to the MetNIQ complex and the lower one to free transporter by 
comparison to E166Q MetNI alone (Fig 2.1b., lane 1). 
Wild type MetQ contains a co-purifying methionine identified in the crystal 
structures of MetQ homologs S. aureus lipoprotein-9 (PDB entry 1P99, (Williams et al., 
2004)), T. pallidium Tp32 (PDB entry 1XS5, (Deka et al., 2004)), E. coli MetQ (Kadaba, 
2008), N. meningitides (PDB 3IR1, (Yang et al., 2009)), V. vulnificus (PDB 3K2D, (Yu et 
al., 2011)) and unpublished structures with PDB entries 3TQW, 3UP9, 4EF1, 4GOT, 4IB2, 
4K3F, 4QHQ, 4QYM, and 4Q5T. The basic structure and binding site for L-methionine 
are illustrated in Fig. 2.2a for E. coli MetQ refined at 1.6 Å resolution (PDB entry 4YAH, 
see Methods). An extensive hydrogen bond/salt bridge network between protein side 
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chains and the methionine amino and carboxyl groups likely contributes to the tight binding 
of ligand to MetQ (Fig 2.2b). Groups interacting with the carboxyl group of methionine 
include the side chains of Arg144, Asn202, and a buried water, while the amino group 
interacts with the side chains of Glu42 and Thr204 and two buried waters (Fig 2.2b). 
Significantly, the side chain of Asn229 forms two hydrogen bonds (one each) to the amino 
and carboxyl groups of the L-methionine (Fig 2.2b). The side chain of the bound L-
methionine fits in a pocket surrounded by the aromatic side chains of Tyr69, Phe86, His88, 
and Tyr91 (Fig 2.2b). Aromatic interactions with the methionine side chain are not 
uncommon (Pal and Chakrabarti, 2001), particularly the interaction observed with the 
ligand SD packed against the plane of His88 such that the CG-SD bond is oriented towards 
the NE2 atom of His88. 
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Figure 2.2. The crystal structure of E. coli L-methionine-bound MetQ 
a. Ribbon diagram of L-methionine-bound E. coli MetQ.  
b. The L-methionine binding site in MetQ. The side chains of the interacting residues are 
colored green, and the L-methionine substrate is colored grey. Hydrogen bonds between 
the amino and carboxyl groups of L-methionine and surrounding MetQ residues are 
represented by yellow dashes. 
 
To evaluate the contribution of L-methionine binding to MetQ to the stability of 
the MetNIQ complex, it is necessary to prepare ligand-free MetQ. While methionine can 
be removed from MetQ by an unfolding/refolding process (Deka et al., 2004), we 
developed an alternative approach of using alanine-scanning mutagenesis to identify MetQ 
mutants that disrupt the binding of L-methionine. Residues in the MetQ binding pocket in 
contact with methionine were mutated to alanine (Fig. 2.3), with the exception of Glu42, 
which was substituted with Gln (E42Q) since the E42A mutant aggregated.  
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Figure 2.3. Screening for substrate-binding-deficient MetQ mutants 
Alanine-scanning mutants of MetQ were analyzed for selenium content by ICP-MS after 
exchange of native substrate with L-selenomethionine (see text). The horizontal and 
vertical axes denote the MetQ mutations and fraction of MetQ bound by selenomethionine, 
respectively. Error bars represent the standard deviation of duplicate samples. 
To test for L-methionine binding, we unfolded MetQ in 6 M guanidine-HCl to 
release any co-purified L-methionine (Deka et al., 2004), and then refolded the protein in 
the presence of L-selenomethionine. Selenium content was measured by inductively 
coupled plasma mass spectrometry (ICP-MS), and the molar ratio of selenium to MetQ 
was calculated (Fig. 2.3). Mutation of Glu42 to Gln (E42Q) and Asn229 to Ala (N229A) 
significantly decreased the binding affinity of MetQ to selenomethionine, while 
substitutions at other residues had relatively little effect on selenomethionine binding. The 
E42Q and N229A MetQ mutants, identified in this screen as unable to bind 
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selenomethionine (and presumably methionine), were then tested for complex formation 
with E166Q MetNI in the presence of ATP+EDTA. The E42Q mutant was unable to form 
a complex with its cognate transporter (data not shown). When N229A MetQ was 
incubated with E166Q MetNI in the presence of ATP+EDTA, however, stoichiometric 
complex formation was observed (Fig. 2.1b, lane 4). This result contrasts with the mixture 
of free and complexed species observed when E166Q MetNI is incubated with wild type 
liganded MetQ under comparable conditions (Fig. 2.1b, lanes 2 and 3). Based on these 
results, the N229A MetQ variant was used in this study to mimic methionine-free MetQ. 
To quantify the binding affinity of E166Q MetNI for MetQ in either the bound or 
unliganded state, we measured the dissociation constants for complex formation from 
titration curves conducted with fluorescently labeled MetQ on a Monolith NT.115 
Microscale Thermophoresis Instrument (NanoTemper Technologies GmbH). Wild type 
and N229A MetQ were labeled with Cy3-maleimide and titrated with varying 
concentrations of E166Q MetNI in the presence of ATP+EDTA. The fraction of MetQ in 
complex with E166Q MetNI was calculated from fluorescent intensity values (see 
Methods). The affinity of L-methionine-bound wild type MetQ for E166Q MetNI was ~40-
fold weaker than that for unliganded N229A MetQ to E166Q MetNI (Fig 2.4). The 
calculated Kd of 1100 ± 300 nM for wild type MetQ represents a lower limit for the affinity, 
as saturating amounts of E166Q MetNI were prone to aggregation. The Kd for N229A 
MetQ was determined to be 27 ± 9 nM. This difference in affinity is qualitatively consistent 
with our BN PAGE results (Fig 2.1b). 
We have identified conditions promoting stable complex formation between MetNI 
and MetQ through the use of two mutations (the E166Q variant in the Walker B motif of 
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MetN that reduces ATP hydrolysis, and the N229A variant of MetQ that disrupts 
methionine binding) and the presence of ATP+EDTA to reduce the concentration of Mg2+ 
critical for ATP hydrolysis. These conditions should stabilize the ATP-bound form of 
MetNI, corresponding to the outward facing conformation of a Type I ABC transporter 
(Oldham and Chen, 2011). An unexpected feature of the MetNI system is that the use of 
ligand free MetQ resulted in stable complex formation, in contrast to the maltose 
transporter system where formation of a stable transporter-SBP complex required the 
presence of the transported substrate (Chen et al., 2001; Oldham et al., 2007). In the 
absence of ATP, a "pre-translocation" species has also been crystallized with substrate-
loaded SBP and an inward facing conformation of the transporter for the molybdate 
(Hollenstein et al., 2007) and maltose (Oldham and Chen, 2011) transporters.  While the 
corresponding complex between liganded SBP and the methionine transporter is 
substantially less stable (Kd ~ 7.5 x 10-5 M (Lewinson et al., 2010)) than the complex in 
the presence of ATP measured in this work (Kd ~ 10-6 M), at the protein concentrations 
(~10-4 M) used in crystallization trials, perhaps this state of the MetNIQ complex could 
also be crystallized under appropriate conditions.  
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Figure 2.4. Dissociation constants between MetNI and MetQ 
The affinity of MetNI for MetQ was measured by titration curves using fluorescently 
labeled MetQ in the presence or absence of bound methionine (wild type or N229A MetQ, 
respectively). All experiments contained 1 mM ATP and 1 mM EDTA. 101 nM of Cy3-
labeled wild type MetQ was titrated with 1.95 nM – 32 µM non-labeled E166Q MetNI 
(closed squares). 99 nM of Cy3-labeled N229A MetQ was titrated with 1.95 nM – 4 µM 
non-labeled MetNI E166Q (open circles). The dissociation constants calculated from these 
data for wild type (methionine-bound) and N229A (methionine-free) MetQ binding to 
E166Q MetNI are Kd = 1100 ± 300 nM and 27 ± 9 nM, respectively. Error bars represent 
standard error from three independent measurements. 
The role of transported ligand in complex formation is of great mechanistic interest. 
For complex formation between MetNI and MetQ, the difference in dissociation constants 
between unliganded (27 nM) and liganded (1100 nM) MetQ implies that the binding of 
methionine to MetQ in complex with MetNI is ~40-fold weaker than the binding of 
methionine to MetQ alone. Energetically, this observation is consistent with a model where 
the SBP must release ligand for transport to occur. The detailed energetics will certainly 
depend on the transporter and assay conditions; for example, while liganded maltose 
binding protein has been reported to more efficiently stimulate ATP hydrolysis of maltose 
transporter reconstituted into proteoliposomes (Davidson et al., 1992), ligand-free maltose 
binding protein binds 5-fold more tightly than liganded binding protein to maltose 
transporter in nanodiscs with AMPPNP (Kd ~ 80 nM and ~400 nM in the absence or 
presence of maltose, respectively (Bao and Duong, 2012)). An additional complication 
with the MetNI transporter is that methionine is both a transported ligand and an allosteric 
  
26 
inhibitor of transport, and these effects will need to be distinguished from the contributions 
of the liganded state of MetQ to the observed kinetics. The development of a detailed 
molecular transport mechanism will require analysis of conformational dynamics of the 
type recently described for the GlnPQ uptake system (Gouridis et al., 2015). The structural 
analysis of stable forms of ABC transporters such as the MetNIQ complex detailed here 
will provide crucial reference states for these future mechanistic studies. 
2.3. Materials and methods 
2.3.1. Cloning, expression and purification of MetQ 
The metNIQ operon was amplified from Escherichia coli K-12 genomic DNA and 
cloned into a zero blunt pCR-4 TOPO vector as described in (Kadaba et al., 2008). The 
metQ gene, lacking the stop codon, was subcloned using oligonucleotides that included 
NdeI and XhoI restriction-enzyme sites, and then ligated into the pET21b(+) vector with a 
C-terminal 6x-histidine tag. The cloned plasmids were expressed separately in E. coli BL21 
(DE3) gold cells (EMD) at 37 °C in Terrific Broth medium with 100 μg/ml ampicillin. The 
cells were induced at OD600 ~4.0 with 0.4 mM IPTG for 2 hours, then harvested and stored 
at -80 °C. 
For purification of mature MetQ, periplasmic extract was prepared by resuspending 
10 g of cell paste in 10 ml of 40% sucrose, 10 mM Tris-HCl pH 7.5, and 1 mM EDTA, and 
stirred for one hour at room temperature. The cells were then shocked by addition of 500 
ml of ice-cold water. After stirring for 10 min, buffer components were added to a final 
concentration of 25 mM Tris pH 7.5, 150 mM NaCl, and 17 mM imidazole. The resulting 
suspension was then centrifuged at 37,500 x g for 30 min to remove all cellular debris from 
the periplasmic extract. MetQ was isolated from the periplasmic extract by immobilized 
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metal ion affinity chromatography using a 5 ml Ni-NTA column (GE). The affinity column 
was washed with 25 mM Tris pH 7.5, 150 mM NaCl, and 17 mM imidazole for 10 column 
volumes. Protein was then eluted from the column using 25 mM Tris pH 7.5, 100 mM 
NaCl, and 150 mM imidazole. Peak fractions were dialyzed against 25 mM Tris pH 7.5 
and 150 mM NaCl overnight, and then concentrated to 30 mg/ml using a 10kD MWCO 
concentrator (Millipore). 
The full-length protein cloned for this work, including the signal sequence and the C-
terminal 6x-his tag, has the sequence: 
  1 MAFKFKTFAAVGALIGSLALVGCGQDEKDPNHIKVGVIVGAEQQVAEVAQKVAKDKYGLD  
 61 VELVTFNDYVLPNEALSKGDIDANAFQHKPYLDQQLKDRGYKLVAVGNTFVYPIAGYSKK 
121 IKSLDELQDGSQVAVPNDPTNLGRSLLLLQKVGLIKLKDGVGLLPTVLDVVENPKNLKIV  
181 ELEAPQLPRSLDDAQIALAVINTTYASQIGLTPAKDGIFVEDKESPYVNLIVTREDNKDA  
241 ENVKKFVQAYQSDEVYEAANKVFNGGAVKGWLEHHHHHH 
The cleaved signal sequence is highlighted in bold, so that the purified protein used 
in this study consists of residues 17 to 279, of which residues 29-273 (underlined) are 
observed in the electron density. 
2.3.2. Purification of MetNI 
Purification of wild type and mutant E166Q MetNI was carried out as described 
(Johnson et al., 2012) with the one modification that buffer containing 20 mM TAPS pH 
8.5, 100 mM NaCl and 0.025% DDM (with varying amounts of imidazole) was used in all 
purification steps (the original protocol used 250 mM NaCl and different detergents).  
2.3.3. MetQ crystallization and structure determination  
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Crystallization conditions for MetQ were screened with varying concentrations of 
protein from 15 mg/ml to 60 mg/ml. Crystals were obtained using a hanging drop vapor 
diffusion method at 20° C, by mixing 1 μl of protein to 1 μl of the following well solution: 
24% PEG 4000, 4% PEG 400, 0.1 M sodium citrate pH 5.6, and 0.2 M ammonium acetate 
at 30 mg/ml of protein, similar to the conditions originally described (Kadaba, 2008). Initial 
thin needle crystals appeared within a week but crystals were not large enough for data 
collection. Both microseeding and macroseeding were used to obtain larger crystals, 
reaching a final size 0.5 x 0.2 x 0.1 mm3 in a week. The best crystal was obtained by 
macroseeding with a precipitant 20% PEG 4000, 3% PEG 400, 0.1 M sodium citrate pH 
5.6, and 0.2 M ammonium acetate. Diffraction data to 1.6 Å resolution were collected at 
the Stanford Synchrotron Radiation Lightsource (SSRL) on beamline 12-2. The data was 
processed using xia2 (Winter, 2010) using XDS (Kabsch, 2010), XSCALE, and AIMLESS 
(Evans, 2006), with data collection and processing statistics listed in Table 1. Molecular 
replacement was performed using Phenix (Adams et al., 2010) from the previously solved 
1.8 Å resolution MetQ structure (Kadaba, 2008) that was in turn solved by molecular 
replacement from PDB entry 1P99 (Williams et al., 2004), a Gly-Met-binding protein. The 
structure was refined with Phenix to 1.6 Å resolution to a final R/Rfree of 0.154/0.183. 
Coordinates and structure factors have been deposited in the Protein Data Bank of the 
Research Collaboratory for Structural Bioinformatics, with ID 4YAH. 
2.3.4. Screening of substrate-binding deficient MetQ mutants  
Individual residues located in the substrate-binding pocket of MetQ were 
substituted with alanine by site-directed mutagenesis using the Quickchange Mutagenesis 
kit (Stratagene), with the exception of Glu42, which was substituted with glutamine to 
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avoid aggregation. To evaluate the binding ability of each mutant for substrate, L-
methionine was exchanged with L-selenomethionine, and the amount of selenium was 
measured using inductively coupled plasma mass spectrometry (ICP-MS).  
To exchange L-methionine with L-selenomethionine, individual MetQ mutants 
immobilized onto Ni-NTA columns were unfolded by washing with 12 column volumes 
of denaturing buffer containing 6 M guanidine-HCl, 25 mM Tris pH 7.5, 150 mM NaCl at 
the rate of 1.5 ml/min to remove bound L-methionine. To refold MetQ, guanidine-HCl was 
slowly removed by flowing renaturation buffer (2 mM L-selenomethionine, 25 mM Tris 
pH 7.5, 150 mM NaCl) over the column at 1 ml/min for 90 min. The column was further 
washed with 10 column volumes of renaturation buffer to ensure reloading of MetQ with 
L-selenomethionine. This was followed by 12 column volumes of wash buffer (25 mM 
Tris pH 7.5 and 150 mM NaCl) to remove unbound L-selenomethionine. Finally, MetQ 
was eluted in 25 mM Tris pH 7.5, 150 mM NaCl, and 150 mM imidazole, and run over a 
size-exclusion column (Superdex 200 16/60, GE Healthcare) equilibrated in 25 mM Tris, 
pH 7.5 and 150 mM NaCl. The monodisperse peak was collected and concentrated to 20 
mg/ml using an Amicon 10-kD MWCO concentrator (Millipore). 
The amount of bound L-selenomethionine was measured by quantitation of the 
selenium content of acid-digested protein samples using ICP-MS. A final concentration of 
0.1 μM of protein was digested with 2% trace metal grade nitric acid (Fluka) at 70  °C 
overnight. Samples were centrifuged at 30,000 x g for 10 min using a bench top centrifuge 
to remove particulate matter. The supernatant was then diluted to a final volume of 5 ml in 
double distilled H2O and measured for Se78 with an HP 4500 ICP-MS instrument. L-
selenomethionine powder stock (Anatrace) was used to prepare standards. Each sample 
  
30 
was measured in duplicate in two independent experiments. Error bars represent standard 
deviation. Data were processed and graphed using Microsoft Excel and Sigmaplot 11.0, 
respectively. 
2.3.5. Qualitative determination of complex formation  
MetNI and MetQ concentrations were measured using a Nanodrop 2000 
Spectrophotometer (Thermo Scientific), according to their calculated extinction 
coefficients for a 1 mg ml-1 solution at 280 nm of 0.64 and 0.73, respectively. Complex 
formation was assessed by mixing E166Q MetNI transporter and its cognate binding 
protein, MetQ, at a molar ratio of 1:1.25 (MetNI: MetQ) in the presence of 1 mM ATP and 
1 mM EDTA. The mixture, containing 40 μM MetNI, 50 μM MetQ, 1 mM ATP, 1 mM 
EDTA, 20 mM TAPS pH 8.5, 100 mM NaCl, 0.025% DDM, and 5 mM -
mercaptoethanol, was incubated for 1 hour at room temperature and ultracentrifuged at 
200,000 x g for 20 min to remove any aggregation. Samples were injected onto a Superdex 
S200 10/300 sizing column (GE Healthcare) equilibrated with buffer containing 20 mM 
TAPS pH 8.5, 100 mM NaCl, 0.5 mM ATP, 1 mM EDTA, 0.3% Cymal-5, and 5 mM β-
mercaptoethanol. The absorbance reading at 280 nm and the retention volume of the peak 
were used to follow complex formation. MetNIQ complex formation was verified by 
analyzing the highest peak by BN PAGE (Reisinger and Eichacker, 2006) using 4-20% 
Criterion gels (Bio-Rad). Two independent experiments were conducted per condition.  
2.3.6. Measurement of MetNIQ complex dissociation constant  
The E. coli MetQ sequence contains one cysteine residue at amino acid position 23. 
Purified wild type MetQ and N229A MetQ were labeled with Cy3-maleimide (GE 
Healthcare), according to the manufacturer’s instructions, in buffer containing 25 mM Tris 
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pH 7.5, 150 mM NaCl, and 10 mM TCEP pH 7.5. Unreacted dye was removed using a 
Superdex 200 10/300 GL column (GE Healthcare) equilibrated with the aforementioned 
buffer condition. The label to protein ratio was determined using a NanoDrop 2000 
Spectrophotometer (Thermo Scientific) at 550 and 280 nm, and a labeling efficiency of 
10% was calculated. Fluorescence measurements were performed on a Monolith NT.115 
Instrument (NanoTemper Technologies GmbH) at 25 °C using standard capillaries. 
Varying concentrations (ranging from 1.95 nM to 32 µM) of unlabeled E166Q MetNI in 
ATP buffer (1 mM ATP, 1 mM EDTA, 20 mM TAPS pH 8.5, 100 mM NaCl, and 0.3 % 
Cymal-5) were titrated against a constant concentration of MetQ (101 nM of wild type 
MetQ or 99 nM of N229A MetQ). Fluorescent intensity as a function of E166Q MetNI 
concentration was normalized to fraction bound by averaging the intensity values for the 
lowest three concentrations of E166Q MetNI per experiment.  This background intensity 
was subtracted from all concentrations to yield corrected intensity values. The corrected 
intensity values were then divided by the corrected intensity at the highest concentration 
of E166Q MetNI to normalize intensity values to fraction bound values.  Dissociation 
constants for wild type MetQ or N229A MetQ binding to E166Q MetNI were calculated 
using the Kd Fit function of the NanoTemper Analysis 1.5.41 software. Three independent 
MST measurements per condition were conducted, and error bars represent standard error 
of the mean. 
Table 2.1. Data processing and refinement statistics  
Data Processing Statistics MetQ 
Space group C2221 
Unit cell dimensions (a, b, c) (Å) 59.7, 87.4, 112.9 
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Wavelength (Å) 1.00 
Resolution (Å)a 
24.5-1.60 
(1.64 – 1.60) 
Unique reflections 38,555 
Redundancy 4.1 
Completeness (%) 98.4 (96.1) 
I /  11.5(1.11) 
Rmerge 0.07 (0.952) 
Refinement Statistics PDB ID 4YAH 
Resolution (Å)a 
24.5 – 1.60 
(1.64 – 1.60) 
R-work 0.154 (0.360) 
R-free 0.183 (0.409) 
Average B factor (Å) 27.7 
RMSD bond length (Å) 0.008 
RMSD bond angle ( ° ) 1.21 
Ramachandran plot 
(favored, allowed, outliers, %) 
98, 2, 0 
aNumbers in parentheses represent data in the highest resolution shell 
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CHAPTER 3 
AN UNCONVENTIONAL MECHANISTIC MODEL FOR THE ESCHERICHIA 
COLI TYPE-I METHIONINE ABC TRANSPORTER 
 
3.1. Introduction 
A methionine transporter is a highly-conserved bacterial ABC importer that 
consists of four typical subunits: two transmembrane subunits (MetI) that form a 
translocation pathway, and two nucleotide-binding subunits (MetN) that use the energy 
from ATP binding and hydrolysis to fuel transport 1–4. An ABC importer requires an 
additional component, a substrate-binding protein (SBP), located in the periplasm of Gram-
negative bacteria or tethered to the membrane in Gram-positive bacteria and archaea, to 
deliver substrates to their cognate transporters. For the methionine transporter, the 
methionine-binding protein, MetQ, serves as the substrate-binding protein 5,6 
The transport mechanism of the methionine transporter is best described by the 
alternating access model 7,8, in which the transport cycle interconverts between an inward-
facing conformation that opens the translocation pathway to the cytoplasm, and an 
outward-facing conformation that opens it to the periplasm. Structures of transporters in 
complex with their binding proteins 9–14 have been instrumental in defining the basic 
features of the transport cycle. The two best characterized ABC importers are the type I 
(small transmembrane subunits, 5-8 helices per subunit) maltose uptake system, MalFGK2, 
and the type II (large transmembrane subunits, 10 helices per subunit) vitamin B12 uptake 
system, BtuCD. Structural studies on these importers have provided two renowned 
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mechanistic models for the transport cycles of type I and type II ABC transporters, although 
recently they have been challenged by biochemical and single molecule studies 15,16. Bao 
and Duong 15 showed that the apo form of maltose-binding protein binds to nanodisc-
incorporated maltose transporters with high affinity, and that this complex facilitates the 
acquisition of maltose into the translocation pathway. In addition, single molecule studies 
on proteoliposome-incorporated vitamin-B12 transporters, Goudsmits et. al. also pointed 
out that apo binding protein BtuF forms a stable complex with the BtuCD transporter at a 
ground state in the absence of ATP and substrate 16. Substrate is caught by the BtuCD-
complexed BtuF, and then shuttled inside the translocation pathway 16.  
Although the methionine transporter belongs to type I ABC transporter family, 
previous works revealed unique features, which include (1) the C-regulatory (C2) domains 
17,18 and trans-inhibition regulation, in which binding of L-methionine to these domains 
inhibit transport and ATPase activity  19,20, (2) the low binding affinity of substrate-bound 
(holo) MetQ for ATP-free MetNI (Kd ~ 10-4 M) (Lewinson, Lee, Locher, & Rees, 2010) 
and ATP-loaded MetNI (Kd ~ 1.1 M) 22, and (3) the high affinity of substrate-free (apo) 
MetQ for ATP-loaded MetNI (Kd ~ 27 nM) 22.  
Currently, only the IWF conformation of MetNI has been solved 
crystallographically 17,18. To build a comprehensive model for MetNI transport, we have 
solved a 2.95Å resolution crystal structure of the ATPɣS-bound MetNIQ complex in a 
catalytic intermediate state. The structure sheds light on the mechanism of the methionine 
transporter and its regulation by trans-inhibition. In addition, this structure also reveals 
unexpected features of the binding protein MetQ in complexed form. Coupling structural 
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and functional characterization of the MetNI methionine transporter, we propose an 
unconventional mechanistic model for type-I methionine ABC transporter. 
3.2. Results and Discussion 
3.2.1. Overall architectures of the MetNIQ complex in the outward-facing 
conformation  
We determined a 2.95Å resolution crystal structure of the methionine-ABC 
transporter, MetNI, in complex with its substrate-binding protein, MetQ (Fig3.1a). 
Significant conformational changes of MetNI subunits are observed, relative to the 
uncomplexed MetNI (Fig 3.1a). Superimposition of one MetI subunit of the OWF (shown 
in pale green) to that of the IWF conformation (shown in gray) (PDB: 3TUI) reveals a 
rotation of about 31o along the rotation axis, shown in red (Fig 3.11). This rotation results 
in a large movement of the opposite subunit in a shift of approximately 15Å as a whole 
rigid body, opening the translocation pathway toward the periplasm (Fig 3.1b).  
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Figure 3.1. Structure of MetNIQ complex. (a) side-view representation of the MetNIQ. 
MetQ subunit is colored state, MetI subunits pale green and salmon, and MetN subunits 
tv_orange and wheat, C-regulatory (C2) domains are at the C-termini of MetN subunits. 
a, c, d, conformational changes of the transmembrane MetI subunits (b), the nucleotide-
binding MetN subunits (c), and the C2 domains (d) between their outward-facing (OWF) 
(colored as described in (a)) and inward-facing (IWF) conformation (colored in gray). 
One subunit of MetI (pale green) or MetN (tv_orange) of the OWF conformation was 
overlaid to that of the IWF conformation to highlight the differences in the relative 
placement of the opposite subunit (b), (c). Superimposition of MetNIQ and MetNI reveals 
the rotation of the C2 domains (d). 
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To visualize the movements of the nucleotide-binding domains of the MetN 
subunits from the IWF to OWF conformation, the two halves of the transporter (MetN, 
MetI) from the two conformations (PDBs: 6CVL and 3TUI) were superimposed using the 
transmembrane domain as a fixed domain. As a result, the NBD rotates about 18o along the 
rotation axis, shown in magenta (Fig 3.11) relative to that in its IWF to adopt its new OWF 
conformation. The distance between the two nucleotide-binding domains is reduced by 
about 14Å (Fig 3.1c), some of which allows dimerization of two NBDs in the presence of 
ATPS. At the C2 domains, unlike those of the maltose transporter, a twist with an angle 
of 32o (Fig 3.1d) along the rotation axis, shown in yellow (fig3.11) was observed between 
this structure and the DM solubilized MetNI (PDB: 3TUJ) 18. This unique feature is 
possibly involved in the trans-inhibition event. Our previous work showed that binding of 
L-methionine to the C2 domains locked the NBDs into the inward-facing conformation 18. 
In this L-methionine-bound, IWF/inhibited conformation 18, an L-methionine substrate 
from one C2 domain forms hydrogen bonds with the other substrate at the interface β-sheet, 
stabilizing the inward-facing conformation of the transporter (Fig 3.6a). In contrast, the 
OWF configuration shows a repositioning of the C2 domains by a register shift of the 
hydrogen bonding network between the two intermolecular β-sheets (A299 – A299 in the 
IWF to A299 – M301 in the OWF) (Fig3.6c, d). This flexibility of the C2 domains results 
in the dimerization of MetN subunits in the presence of ATP. 
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Figure 3.2. Translocation pathways of different ABC importers at a glance. a, Surface slab 
views of the outward-facing conformations of three ABC importers, including MetNIQ 
(unpublished), MalFGK2 (PDB: 2R6G), and BtuCDF (PDB: 4FI3), reveal potential 
substrate-binding pockets (red box) with different sizes and shapes at the translocation 
pathways. While MetI subunits form a small cavity, larger cavities are observed in the case 
of maltose and vitamin-B12 transporters. Only maltose (shown in ball and stick) was 
structurally observed in the cavity. b, Potential different mechanisms of substrate delivery 
were observed in the three ABC importers mentioned in a. While “scoop loop” was 
  
44 
proposed for substrate handing between the maltose-, and vitamin-B12-binding proteins 
to their transporters, no “scoop loop” was found in the methionine transporter 
3.2.2. Unexpected features of MetQ in complex with MetNI indicate new substrate 
delivery mechanism 
Structures of the maltose (PDB: 2R6G) 11 and vitamin-B12 (PDB: 4FI3) 10 
transporters revealed insertion loops, aka “scoop loops”, from the transmembrane subunits 
into the substrate cavities of the binding proteins that facilitate substrate hand-off (fig3.2b). 
No such scoop loop was found in the MetNIQ complex (fig3.2b). This may indicate that 
another substrate hand-over mechanism is involved. 
The crystal structure of the MetQ in complex with the MetNI transporter 
(complexed MetQ), (reported here) reveals a conformation distinct from the substrate-free 
(apo) (reported here) and substrate-bound (holo) (PDB: 4YAH) conformation (fig 3.3a, b). 
Superimposition of the open (apo) to the complexed MetQ structure shows a 44o-angle 
hinge-type rotation between two lobes of MetQ (fig3.3a, fig3.11). On the other hand, a 24o- 
angle twist twofold axis (fig3.3b, fig3.11) was found in the complexed form compared to 
the holo form of MetQ with an rmsd of 4.4 Å. This distortion is larger than that of the 
maltose-binding protein, MalE (rmsd=0.7 Å) and of the vitamin-B12 binding protein, BtuF 
(rmsd=1.0 Å). We suspect that this distortion, together with the small size of the methionine 
substrate, may allow methionine to access not only the MetQ binding cavity but also the 
MetNIQ translocation pathway (fig 3.4).  
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Figure 3.3. An unexpected third conformation of MetQ in complex with MetNI. The crystal 
structure of MetQ subunit in complex with MetNI (complexed MetQ) (colored state) shows 
another distinct conformation different from the substrate-free (apo) (colored raspberry) 
and substrate-bound forms (holo) (colored cyan). Superimposition of the apo and 
complexed MetQ shows a typical “hinge-type” rotation with a rotation angle of 42o, while 
a twist 24o was observed along a different axis in the superimposition of the complexed 
versus holo MetQ (b). 
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Figure 3.4. Potential substrate pathways for the MetNIQ complex. A twisted conformation 
of the MetQ in complex with MetNI results in wide open cavities, which are accessible for 
different substrate pathways shown as surface representations. These pathways were 
calculated by CAVER 3.0.2 pymol plugin. 
3.2.3. Substrate cavity and gating mechanism  
Rearrangements of the cytoplasmic and periplasmic gates were observed in the 
MetNIQ crystal structure (fig3.5a). At the periplasmic gate, residues Y177 and M163 move 
away from the center of the translocation pathway, compared to those in the IWF 
conformation of MetNI (Fig3.5b, c). On the other hand, residues M107 (TM3) from both 
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MetI subunits form a cytoplasmic gate, the bottleneck of the translocation pathway (Fig 
3.5d, e). 
 
Figure 3.5. Conformational changes of the cytoplasmic, periplasmic gates and C2 domains 
of the MetNIQ complex. a,b, Structure comparison of the MetI subunits in their outward-
facing conformation (colored pale green and salmon) (left boxes) versus inward-facing 
conformation (colored white and gray) (right boxes) reveals major rearrangements of the 
periplasmic gate residues, including Y177 and M163 (a), and of the cytoplasmic gate 
residues, including F103, M107, and Y160 (b).  
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Figure 3.6. Hydrogen-bonding shifts at the interface of C2 domains. Top-down view (d, e) 
of the C2 domains of the outward-facing conformation MetNIQ (OWF conformation) 
reveals shifts in hydrogen-bonding network (yellow dashes) A299 – M301, compared to 
that of the inward-facing conformation MetNI (b, c) (IWF/inhibited conformation), A299 
– A299 between 2 β-sheets (shown in ball-and-stick representations) at the domains’ 
interface. Binding of L-semethionine (MSE) at the C2 domains stabilizes the A299 – A299 
hydrogen bond, and consequently locks the MetNI in its inward-facing conformation 
(PDB: 3TUZ). 
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Rearrangements of the MetI subunits in the OWF conformation create a small 
cavity (fig3.2a), whose boundary is defined by residues Y160 and F103 at the top and 
bottom of the cavity respectively (fig3.5b), along the translocation pathway of the MetNIQ. 
Compared to the known substrate cavities, in the maltose and vitamin-B12 transporters 
11,13, this cavity is the smallest one, and proportional to the size and shape of the transported 
methionine substrate (fig3.2a). We didn’t find any methionine binding site in the 
translocation pathway of MetNIQ either structurally after crystal soaking or biochemically 
by isothermal calorimetry (ITC) measurement. This differs from the maltose transporter 
that maltose is found in the translocation pathway 11; the presence of vitamin-B12 in the 
translocation pathway has also been inferred biochemically 13. Interestingly, in MetNIQ, 
Y160, F103, and M107 residues from both subunits line the translocation pathway as if to 
form a “selectivity filter” for methionine selection (Fig3.5b). Aromatic rings from these 
residues may favor a selection toward the sulfur atom of the methionine residue.  
3.2.4. The effects of L-methionine to complex formation and stability of MetNIQ 
complex 
L-methionine was shown to inhibit the ATPase activity of MetNI, possibly by 
binding to the C2 domain and preventing MetN subunits from associating and hydrolyzing 
ATP 17–19. As a consequence, this binding event may inhibit complex formation. We sought 
to reveal the effect of L-methionine on the complex formation of MetNIQ. MetNI was pre-
incubated with L-methionine at different ratios (1: 0 to 1: 100, MetNI: L-methionine) and 
mixed with  apo MetQ (N229A) in the presence of ATP-EDTA to form the complex. These 
reactions were then separated by gel filtration to purify potential MetNI(Q) peaks, and 
analyzed by SDS-PAGE (Fig 3.7a). MetNIQ complex formation was inhibited by the 
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presence of L-methionine at a ratio of 1: 10 (MetNI: L-methionine) or higher (Fig 3.7b), 
suggesting that binding of L-methionine to the C2 domains prevents the stable association 
of MetNI with MetQ. To test whether L-methionine can destabilize preformed MetNIQ 
complexes, we set up another set of reactions in which the pre-formed MetNIQ was mixed 
with L-methionine at different ratios. SDS-PAGE analysis of the MetNIQ peaks showed 
that the complex largely remains intact at the tested ratios (1: 0 to 1: 100, MetNIQ: L-
methionine) (Fig 3.7c).  
 
Figure 3.7. The effects of L-methionine on MetNIQ complex formation and stability. a, 
Experimental setup to observe complex formation or dissociation in the presence of L-
methionine. In reaction 1, L-methionine pre-incubated MetNI (E166Q) at different ratios 
was mixed with MetQ (N229A) in the presence of ATP-EDTA for complex formation, which 
was detected by gel filtration and SDS-PAGE. In reaction 2, pre-formed MetNIQ complex 
was incubated with L-methionine at different ratios, and complex dissociation assessed by 
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gel filtration and SDS-PAGE. SDS-PAGE results of the MetNI(Q) peaks from gel filtration 
of the set of reactions #1 (b) show inhibition of MetNIQ complex formation by L-methionine 
(b) at a ratio of 1: 10 (MetNI: L-methionine). This indicates that binding of L-methionine 
locks the MetNI in its inward-facing conformation, preventing MetN subunits from 
dimerization; however, the preformed MetNIQ complex is stable in the presence of L-
methionine at a highest tested ratio of 1: 100 (MetNIQ : L-methionine) (c) 
3.2.5. Functional characterization of the MetNI methionine transporter confirms 
new roles of the binding protein MetQ 
Transport assays of the methionine transporter and its mutants were performed in 
vivo using a ΔmetNIQ-knockout E. coli strain. It is known that there are two transport 
systems in E coli that are responsible for methionine uptake 23. One is the MetNIQ transport 
system (MetD operon) and the other is an uncharacterized MetP 6. While MetD can 
transport both L- and D-isomers of methionine, MetP can only transport L-methionine 
6,23,24. To selectively study MetNI transport, we took advantage of its unique feature of D-
methionine transport and used a D-methionine derivative, namely D-selenomethionine, as 
the transport substrate for quantification by ICP-MS (Fig3.8a). Kinetic constants for the 
transport activity of D-selenomethionine derived from Michaelis-Menten analysis 
(Fig3.8b) are shown in Table 1. The maximal uptake rate of the wild-type MetNIQ is 6.3 
± 0.4 nmol/min/mg of transporter (n=6) (Fig 3.8b). Since L-methionine is present in the 
cytoplasm at 0.1 – 0.3 mM, to bypass the potential transinhibition effect, a N295A mutation 
at the C2 domain of the MetNI was made to abolish its binding to L-methionine (table 3.2). 
This mutant results in a higher uptake rate of 10 ± 0.5 nmol/min/mg of transporter (n=12). 
A deletion of MetQ yields a poor maximal transport rate of 0.2 ± 0.1 nmol/min/mg of 
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transporter (n=3), which indicates that MetQ is necessary for the transport; however, an 
unanswered question is whether MetQ binds and delivers methionine substrate to the 
transporter. To address this question, we generated a substrate-binding deficient N229A 
mutation that lowers the affinity of MetQ to D-selenomethionine by 10-fold (table 3.2). It 
was unexpected that the N229A MetNIQ mutation stimulates the maximal transport rate 
for D-selenomethionine (Vmax=10.5 ± 0.9 nmol/min/mg of transporter) (n=6) by almost 1.5 
fold compared to the wt MetNIQ (Vmax=6.3 ± 0.4 nmol/min/mg of transporter) (table 3.1). 
A similar stimulation is observed for the N229A mutation of N295A MetNIQ (Vmax=15.4 
± 1.3 nmol/min/mg of transporter) (n=6) compared to the N295A MetNIQ (Vmax=10 ± 0.5 
nmol/min/mg of transporter) (fig3.8b and table 3.1). We hypothesize that binding protein 
is required to stabilize the OWF conformation of MetNI for substrate loading. This 
hypothesis is in agreement with the fact that apo MetQ has a higher binding affinity toward 
ATP-loaded MetNI (Kd ~ 27 nM), but lower to D-selenomethionine (Kd ~7 μM). Hence, 
the apo MetQ binds and stabilizes the OWF-conformation MetNI, some of which opens up 
a translocation pathway for the substrate loading (fig 3.4). At low concentrations of 
substrate, the wild-type (wt) binding protein may recruit substrate to the complex, as 
indicated by a faster transport rate at the lower concentrations of substrate with KM ~1.8 
µM for wt MetNIQ and KM ~1.7 µM for N295A MetNIQ (table 3.2), in compared to higher 
KM observed for the substrate-binding deficient mutants (N229A) for MetNIQ and N295A 
MetNIQ with KM values ~7.4 µM and 4.8 µM, respectively (fig3.8b, table 3.1).  
Mutation of either of the two cytoplasmic gating residues to alanine (F103A, 
M107A) results in no transport activity in vivo (Fig3.8b, table 1), possibly due to 
obstruction of the translocation pathway by non-selected, nonspecific molecules in the 
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periplasm. In contrast, the Y160A mutation results in a gain-of-function mutant, and 
increases the uptake rate by two-fold (Vmax= 14 ± 1.3 nmol/min/mg of transporter) 
compared to that of N295A MetNIQ (Vmax= 10 ± 0.5 nmol/min/mg of transporter). The 
removal of the upper gating residues by Y160A mutation could make the translocation 
more accessible for substrates to get loaded in. 
Table 3.1. Summary of kinetic constants for transport activity of MetNIQ variants. The 
maximum uptake rate (Vmax) and Michaelis-Menten constant (Km) were determined from 
the plot shown in fig3.8. N/A: not applicable; - not detectable. 
MetNIQ variants Uptake rate Vmax  
(nmol/min/mg of transporter) 
Km (µM) 
MetNIQ 6.3 ± 0.4 1.8 ± 0.4 
MetNI 0.2 ± 0.1 N/A 
N295A (EcN) MetNIQ 10 ± 0.5 1.7 ± 0.3 
N229A (EcQ) MetNIQ 10.5 ± 0.9 7.4 ± 0.5 
N295A, N229A MetNIQ 15.4 ± 1.3 4.8 ± 0.7 
N295A, F103A (EcI) MetNIQ -  -  
N295A, M107A (EcI) MetNIQ -  -  
N295A, Y160A (EcI) MetNIQ 14 ± 1.3 4.1 ± 0.2 
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Figure 3.8. In vivo uptake of MetNIQ and its variants. a, Schematic of whole-cell uptake 
assay for MetNIQ variants. b, Michaelis-Menten plot of initial velocities versus substrate 
concentrations for transport activities of MetNIQ and its variants.  
 
3.2.6. Proposed transport mechanism 
The most detailed transport model is built upon structural studies of the maltose 
transporter 12. In this model, MalE delivers ligand to the transporter. However, this model 
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can’t explain (1) the low affinity of substrate-bound MetQ to the IWF conformation MetNI, 
(2) the high affinity of substrate-free MetQ to the ATP-loaded MetNI, and (3) the high 
uptake rate of the substrate-binding deficient mutant of MetNIQ (N229A). Combining the 
structural insights with thermodynamic binding constants and enzyme kinetic transport 
activities, we propose another mechanistic model, illustrated in figure 3.9, to explain the 
biochemical and structural observations for the methionine transporter. A transport cycle 
starts with a resting- state L-methionine-free MetNI (PDB: 3TUJ) that can bind two ATPs 
and acquire the outward-facing conformation MetNI (hypothetical model) (state 2). This 
hypothetical ATP-bound MetNI conformation was modeled based on knowledge of high 
basal ATPase activity of MetNI in the presence of ATP 19, as well as a reported crystal 
structure of AMP-PNP-bound vitamin-B12 transporter trapped by a disulfide bond. The 
ATP-bound MetNI is transient but stabilized by association of the apo MetQ to form the 
MetNIQ complex (reported here) (state 3). Methionine can be loaded into the open 
translocation pathway. Residues Y160, F103, and M107 may form a methionine binding 
pocket in the translocation pathway. Upon ATP hydrolysis, MetNI adopts its post-
hydrolysis ADP-bound inward-facing conformation (PDB: 3TUI), the translocation 
pathway opens towards the cytoplasm, releasing methionine inside the cell (state 4). The 
transporter is ready to bind ATP molecules for the next cycle, unless internal L-methionine 
accumulates to a high concentration in the cell. L-methionine can then bind and lock the 
C2 domains by stabilizing the A299 –A299 hydrogen bonding networks at the C2 domains’ 
interface, and, in turn, arrest MetNI in its IWF (PDB: 3TUZ) (state 5). This arrested IWF 
conformation of MetNI is unlocked by the dissociation of L-methionine molecules (fig3.9). 
The cycle restarts with a resting-state MetNI or an exchange of ADP for ATP for the IWF 
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MetNI. This mechanistic model can be applied for other Type-I ABC importers, and for 
other ABC transporters subjected to trans-inhibition. 
 
 
Figure 3.9. Proposed mechanistic atomic model of the methionine-ABC transporter. The 
states are ordered to demonstrate transport cycle of the methionine transport system, 
including MetNI and MetQ shown in cylinder diagrams. Methionine, ADP, and ATP are 
shown as spheres. State 1, 3, 4, 5 represent crystal structures of MetNI(Q), while state 2 is 
hypothetical model of MetNI based on biochemical evidence of high ATPase activity of 
MetNI in the absence of MetQ. State 1 represents a resting state of MetNI (PDB: 3TUJ) 
with no ADP, no L-methionine. State 2 represents an ATP-bound MetNI with dimerized 
MetN subunits. State 3 represents an ATP-bound MetNI in complex with its binding 
protein, MetQ reported here. At this state, the L/D-methionine can access the translocation 
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pathway of the MetNIQ assembly. State 4 represents an ADP-bound MetNI, a post-
hydrolysis state of MetNI where 2 ADP molecules bound to the MetN subunits (PDB: 
3TUI). Methionine is imported into the cytoplasm upon conformational changes from the 
OWF to IWF conformation. State 5 represents a trans-inhibition event of MetNI where 
excess L-methionine in the cytoplasm binds the C2 domains and locks MetNI in its IWF 
conformation (PDB: 3TUZ).  
Table 3.2. Summary of dissociation constants of methionine to MetNI/MetQ. Binding 
affinities of different methionine isomers and its derivative, selenomethionine were 
measured by heat exchange from Isothermal Calorimetric experiments. N/A: not 
applicable, - not detectable. 
 Substrates 
Proteins L-methionine D-methionine D-selenomethionine 
MetQ 2.3 ± 0.6 nM 7.5 ± 1.9 µM  7.9 ± 1.0 µM 
N229A MetQ 340 ± 50 µM 169 ± 4 µM  80 ± 20 µM  
MetNI 33 ± 4 µM  N/A N/A 
N295A (EcN) MetNI - N/A N/A 
N295A, N229A MetNIQ - - - 
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Fig 3.10. Ellipsoidal truncation and anisotropic scaling of strong anisotropic diffraction 
data. Data observed from a MetNIQ crystal were ellipsoidally truncated and scaled by 
UCLA MBI Diffraction Anisotropy Server (http://services.mbi.ucla.edu/anisoscale). Data 
were truncated at the resolution limits along the directions a*, b*, and c* to resolution 3.2 
Å, 3.3 Å and 3.0 Å respectively, at which F/sigma drops below 3.0. 
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Fig 3.11. Principal component analysis of the methionine structures. Superimposition of 
individual components of the MetNIQ structure to those of the MetNI and MetQ structures 
to calculate the rotation axes (depicted as sticks with angles, cyan: complexed MetQ to 
apo MetQ, blue: complexed MetQ to holo MetQ, magenta: MetN rotation was shown by 
superimposition of MetI from IWF to OWF conformations to reveal the rotation of MetN 
of half transporter MetNI) to go from one conformation to the other, yellow: 
superimposition of the TMDs of MetNI and MetNIQ. Rotation angles were stated as 
degrees 
3.3. Materials and methods 
3.3.1. Cloning, expression, and purification 
The metN and metI genes were amplified from E. coli K12 genomic DNA, and 
cloned into a pET - modified dual vector, under two T7 promoters (pTN2). The metQ gene 
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encoded for a mature MetQ with no signal sequence was cloned into a separate pET19b 
(+) plasmid with N-terminal deca-histidine tag followed by an enterokinase-cleavage site. 
All of the mutations, including E166Q, N295A in MetN; and N229A in MetQ, were done 
by site-directed mutagenesis (Stratagene). The cloned plasmids were expressed separately 
in E. coli BL21-gold (DE3) cells (EMD) at room temperature in ZY media 25.  
Purification of MetNI mutants was carried out by homogenizing 10 g cell paste in 
100 ml of lysis buffer containing 20 mM Tris-HCl pH 8, 100 mM NaCl, 10% glycerol, 5 
mM β-mercarptoethanol (βMe), 20 μg/ml DNAseI, 200 μg/ml lysozyme. The cells were 
broken by three passes through a cell disruptor (M110L pneumatic microfluidizer) 
(Microfluidics). C12E7 was added at a final concentration of 0.5% (v/v) for solubilizing 
membrane fractions at 4oC for 2 hours. Unlysed cells and insoluble membranes were 
removed by centrifugation at 100,000 x g, 4oC, and 30 min. The supernatant was collected, 
added 70 mM imidazole pH 8.0, and loaded to 5 ml Ni-sepharose HP column (GE 
Healthcare) that equilibrated with MetNI’s purification buffer containing 20mM Tris-HCl 
pH 7.5, 100 mM NaCl, 0.1% C12E7, 70 mM imidazole. After sample loading, 12 column 
volumes of the same purification buffer were flowed through to wash non-specific binding 
to the Ni beads. Two column volumes of MetNI’s elution buffer containing 20 mM Tris-
HCl pH7.5, 100mM NaCl, 0.1% C12E7, 300 mM imidazole was used to elute protein off 
the Ni-column. The eluate was then subjected for size-exclusion chromatography. The 
eluted peaks were collected, concentrated, ultracentrifuged (267,000 x g, 20 min, 4oC) to 
remove aggregation, and adjusted to 12 mg/ml. 300ul-per-tube aliquots of MetNI was flash 
frozen by liquid nitrogen (LN2) and stored at -80oC. In preparing MetNI samples for ITC, 
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buffer containing 20 mM TAPS pH8.5, 100 mM NaCl and 0.025% (w/v) DDM was used 
for  
Purification of mature MetQ was done by resuspending 10 g cell paste in 100ml of 
lysis buffer as mentioned above. Cell lysis was done by freezing and thawing for 3 cycles 
in liquid nitrogen (LN2) and in 42oC- water bath respectively. Clearing of cell lysates was 
done by centrifugation at 37,500 x g, 30 min, and 4oC. After the supernatant was collected, 
70 mM imidazole pH 8.0 before was added before loading onto a 5 ml Ni-sepharose HP 
column (GE Healthcare) equilibrated with purification buffer containing 20 mM Tris-HCl 
pH7.5, 100 mM NaCl, 70 mM midazole. After sample loading, 12 column volumes of the 
same buffer were washed through the column to wash non-specific binding to the Ni beads. 
Two column volumes of an elution buffer containing 20 mM Tris-HCl pH 7.5, 100 mM 
NaCl, 300 mM imidazole were used to elute protein off the Ni-column. The eluate was 
then subjected to size-exclusion chromatography. The eluted peaks were pooled, incubated 
with enterokinase, light chain (NEB) to cleave the His tag and passed through a hand-
packed Ni column again to remove uncut MetQ. The His-tag cleaved MetQ was then 
concentrated to 20mg/ml and flash-frozen in aliquots of 300 l per tube. While the E. coli 
N229A MetQ mutant was used for MetNIQ complex formation, the N. meningitides 
N238A MetQ mutant was used for crystallization of an apo MetQ.  
3.3.2. Selenomethionine-substituted proteins 
To prepare selenomethionine-substituted MetNI and MetQ proteins, the cloned 
plasmids were transformed in E. coli auxotroph B834 (DE3) cells (EMD), which were then 
grown in PASM media 25, containing 125 µg/ml selenomethionine for 3- 5 days at room 
temperature.  
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3.3.3. Crystallization of the E. coli MetNIQ protein complex and the apo MetQ 
For crystallization of the native MetNIQ and selenomethionine-substituted 
MetNIQ, the complex formation was described previously. Crystallization screens for 
MetNIQ was done at different concentrations, from 5- 20 mg/ml, by vapor diffusion in 
hanging drops at 20oC using 3 different commercial kits, including memgold-2, 
MORPHEUS (Molecular dimension) and PEGRx (Hampton Research). The MetNIQ was 
crystallized in reservoirs containing 0.1 M MES pH 6 and 22% PEG 400, using 5 mg/ml 
protein at a ratio of protein to reservoir 2: 1. Crystals appeared after 2-3 days, fully grew 
after 5-7 days, and shattered after 10-14 days. Crystals were harvested at day 7 and 
cryoprotected by increasing PEG 400 concentration to 25% and then 30%, and flash frozen 
for data collection. Selenomethionine-substituted MetNIQ and MetQ crystals often 
diffracted better than the native ones. 
3.3.4. Heavy-metal derivatives 
MetNIQ crystals were soaked in crystallization buffer (0.1M MES pH 6 and 22% 
PEG 400) containing 1 mM K2HgI4 for an hour before back-soaking, cryo-protecting and 
flash freezing. 
3.3.5. Crystallization of the MetQ homolog from N. meningitides  
We encountered many challenges in crystallizing the E coli MetQ in either its apo 
or holo forms. Consequently, we tested several homologs of E. coli MetQ and found MetQ 
homolog from Neisseria meningitis that yielded multiple crystal forms. The apo MetQ 
(N238A) from N. meningitis was crystallized in a condition containing 0.2 M MgCl2, 0.1 
M Bis-Tris pH5.5, and 25% PEG3350. Crystals were fully grown after 7 days, and were 
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cryo-protected by increasing PEG concentration to 35% in increments of 5% and flash-
frozen for data collection. 
3.3.6. Data collection and structure determination 
All X-ray diffraction datasets were collected at the Stanford Synchrotron Radiation 
Laboratory (SSRL) beamline 12-2 equipped with a PILATUS 6M PAD detectors. 
Diffraction images were processed and scaled with XDS.  
To determine structure of MetNIQ, several datasets diffracting anisotropically to 4 
Å – 3 Å resolution were collected at the wavelengths of 1.0000 (native crystals) and 
0.09794 (Semet-substituted crystals), respectively. Ellipsoidal truncation and anisotropic 
scaling were applied to the MetNIQ diffraction datasets using the UCLA MBI Diffraction 
Anisotropy server (http://services.mbi.ucla.edu/anisoscale) 26 (Fig. 3.10). All crystals 
belonged to space group P3221 and showed partial twinning with H-alpha twinning 
fractions ranging from 0.10 to 0.176 determined by Xtriage (Phenix) 27; therefore, a twin 
law with operator -h, -k, l was applied. Initial phases were obtained by AutoSol (Phenix) 
using SAD data from a 3.8 Å -selenomethionine derivative crystal and a MalFGK2-E 
(PDB: 2R6H) derived model of MetNI in an OWF conformation as a partial model. MR-
SAD experimental phasing (Phaser-EP, Phenix) using heavy-atom (selenium) sites was 
carried out to reduce model bias. These phases are extended to 3.5 Å resolution and later 
2.95 Å resolution using two other higher resolution datasets. The latter one showed clear 
electron densities for MetQ, which allows us to manually dock two individual lobes of 
MetQ. Additional validation was obtained from the location of mercury sites observed from 
a K2HgI4-soaked MetNIQ crystal that diffracts to 2.95 Å.  The MetNIQ model was refined 
using a combination of Phenix.refine, Rosetta refinement (Phenix) 28, and Refmac5 (CCP4) 
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29. The final model of MetNIQ fits the density for the 2.95Å dataset well with Rwork/Rfree= 
0.23/0.25.  
  To determine structure of an apo N. meningitides MetQ, a dataset of a 
selenomethione derivative crystal diffracted to 1.56 Å resolution was collected at the 
wavelength of 0.9794 Å. The crystal belonged to a space group P21212 with cell dimensions 
of a = 52.56 Å, b = 89.66 Å, c = 45.09 Å. Experimental phasing was performed by Autosol 
(Phenix) with nine selenomethionine sites. Residues were partially built by Autobuild 
(Phenix) and manually using Coot 30. The MetQ model was refined using Phenix.refine 
(Phenix). The final model of the apo MetQ fits the density with Rwork/Rfree= 0.18/0.22. 
3.3.7. In vivo transport assays 
Whole-cell uptake assays were conducted following an established protocol by the 
Poolman lab 31. In brief, different arabinose-inducible (pBAD) plasmids that carry variants 
of metN, metI, and metQ genes were transformed into ΔmetNIQ E. coli strain “BW2115”. 
Cells were grown in LB media to an OD600 of 1.5, induced for 2 hr with 0.2% arabinose 
and harvested by centrifuging for 10 min at 5,000 x g, 4oC. The cell pellets were then 
washed twice in 50 mM sodium phosphate buffer pH 6.5 and resuspended to OD600~10 in 
the same buffer. Before transport assays, cells were energized with 0.5% glucose and 5 
mM MgCl2 for 10 min at 37oC. The transport assays were started by adding D-
selenomethionine at different concentrations at 37 oC, shaking at 300 rpm. The reactions 
were then stopped by centrifugation at 18,000 x g, 4 oC, for 1 min, followed by discarding 
the supernatant. The pellet was washed three more times in the same buffer before 
homogenizing in 20% HNO3. The samples were incubated at 85 oC overnight and diluted 
ten fold for quantifying selenium content by inductively coupled plasma mass spectrometry 
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(ICP-MS) (8800 QqQ, Agilent). The amount of MetNI in each reaction was quantified by 
western blot using anti-his antibody against His-tagged MetN. A correlation between 
different substrate concentrations and uptake rate was shown in a final Michaelis-Menten 
plot (Fig 3.8b) and a summary table (table 3.1). Data were processed using SigmaPlot 10.0 
(SigmaPlot). 
3.3.8. Qualitative determination of complex formation  
Complex formation of MetNIQ and gel filtrations were carried out as described 
previously (Nguyen et al, 2015 with the minor modification that L-methionine was added 
at different concentrations relative to the tested ratios of 1: 0 – 1: 100, MetNI(Q): L-
methionine in a chronological order that is shown in figure 5a. In brief, complex formation 
was assessed by mixing E166Q MetNI transporter and its cognate binding protein, MetQ, 
at a molar ratio of 1: 1.25 (MetNI: MetQ) in the presence of 1 mM ATP and 1 mM EDTA. 
The mixture was incubated for 1 hour at room temperature and ultracentrifuged at 267,000 
x g, 4 oC for 20 min to remove any aggregation. Samples were injected onto a Superdex 
S200 10/300 sizing column (GE Healthcare) equilibrated with buffer containing 20 mM 
TAPS pH 8.5, 100 mM NaCl, 1 mM ATP, 5 mM EDTA, 0.3% Cymal-5. The absorbance 
reading at 280 nm and the retention volume of the peak were used to follow complex 
formation. MetNIQ complex formation was verified by analyzing the highest peak by SDS 
PAGE using any-kD Criterion gels (Bio-Rad). Two independent experiments were 
conducted per condition.  
3.3.9. Isothermal Titration Calorimetry 
MetNI, MetNIQ, and MetQ samples were dialyzed overnight in their purification 
buffers using a Slide-a-lyser mini dialysis device (Thermo Scientific). The samples were 
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then ultra-centrifuged at 267,000 x g, 4oC for 20min to remove aggregates and adjusted the 
concentrations to 100 µM, 100 µM, and 20 µM, respectively. Substrate D-methionine was 
prepared in the last dialysis buffer of each sample. Titrations of D-methionine to MetNI, 
MetNIQ, and MetQ samples were done on a MicroCal iTC-200 calorimeter at 25oC. Data 
were processed using Origin v7.0 (Origin lab).  
Table 3.3. Data collection and refinement statistics for apo MetQ crystal 
Protein name apo NmQ 
Wavelength 0.97946   
Resolution range 34.22  - 1.559 (1.615  - 1.559) 
Space group P 21 21 2 
Unit cell 52.564 89.663 45.088 90 90 90 
Total reflections 103820 
Unique reflections 30754 (2741) 
Multiplicity 6.5(5.4) 
Completeness (%) 98.77 (89.75) 
Mean I/sigma(I) 10.4(2.4) 
Wilson B-factor 17.16 
R-merge 0.167(3.329) 
R-meas 0.182(3.732) 
R-pim 0.071(1.551) 
CC1/2 0.995(0.182) 
Reflections used in refinement 30752 (2741) 
Reflections used for R-free 2000 (179) 
R-work 0.1881 (0.2579) 
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R-free 0.2199 (0.2914) 
Number of non-hydrogen atoms 2143 
  macromolecules 1895 
  solvent 248 
Protein residues 241 
RMS(bonds) 0.003 
RMS(angles) 0.68 
Ramachandran favored (%) 97.49 
Ramachandran allowed (%) 2.51 
Ramachandran outliers (%) 0.00 
Rotamer outliers (%) 0.99 
Clashscore 2.66 
Average B-factor 25.47 
  macromolecules 24.52 
  solvent 32.69 
Number of TLS groups 4 
Statistics for the highest-resolution shell are shown in parentheses. 
 
Table 3.4.  Data collection and refinement statistics for MetNIQ crystal 
(after ellipsoidal truncation and anisotropic scaling) 
Wavelength 1.00582 
Resolution range 39.39  - 2.953 (3.058  - 2.953) 
Space group P 32 2 1 
Unit cell 107.96 107.96 354.52 90 90 120 
Total reflections 
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Unique reflections 42966 (526) 
Multiplicity 19.3(10.5) 
Completeness (%) 83.45 (10.41) 
Mean I/sigma(I) 14.7(1.5) 
Wilson B-factor 
 
R-merge 0.196(26.891) 
R-meas 0.202(28.291) 
R-pim 0.046(10.921) 
CC1/2 0.998(0.052) 
Reflections used in refinement 42968 (528) 
Reflections used for R-free 2174 (29) 
R-work 0.2481 (0.3734) 
R-free 0.2582 (0.4223) 
Number of non-hydrogen atoms 10358 
  macromolecules 10291 
  ligands 67 
Protein residues 1344 
RMS(bonds) 0.012 
RMS(angles) 1.61 
Ramachandran favored (%) 93.32 
Ramachandran allowed (%) 6.38 
Ramachandran outliers (%) 0.30 
Rotamer outliers (%) 1.60 
Clashscore 4.23 
Average B-factor 73.96 
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  macromolecules 74.18 
  ligands 40.31 
Number of TLS groups 18 
Statistics for the highest-resolution shell are shown in parentheses. 
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CHAPTER 4: CONCLUSION 
I would like to use this chapter to summarize our key findings by answering the questions 
that I raised in Chapter 1. 
(1) How does the binding protein interact with its transporter?  
MetNI acquires ATP from the cytoplasm to form ATP-loaded MetNI, which binds 
apo MetQ to form the MetNIQ complex with a dissociation constant measured to be 27 
nM. As shown in this thesis, in the complex, MetQ docks to the transmembrane subunits 
to form a substrate translocation pathway opened to the periplasm (Fig 4.1) 
 
Figure 4.1. 2.95Å resolution crystal structure of the MetNIQ complex 
(2) How does the C-regulatory domains regulate transport of methionine?  
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In an L-methionine-bound, IWF/inhibited conformation 18, an L-methionine 
substrate from one C2 domain forms hydrogen bonds with the other substrate at the 
interface β-sheet, stabilizing the inward-facing conformation of the transporter (Fig4b). In 
contrast, the OWF configuration shows a repositioning of the C2 domains by a register 
shift of the hydrogen bonding network between the two intermolecular β-sheets (A299 – 
A299 in the IWF to A299 – M301 in the OWF) (Fig4.2). This flexibility of the linkers 
between the NBDs and the C2 domains accomodates the dimerization of MetN subunits in 
the presence of ATP, and in the absence of L-methionine. In the presence of L-methionine, 
this rearrangement apparently cannot occur. 
 
 
Fig 4.2. Structural insights of transport regulation by transinhibition 
Top-down view of the C2 domains of the outward-facing conformation MetNIQ (OWF 
conformation) reveals shifts in hydrogen-bonding network (yellow dashes) A299 – M301, 
compared to that of the inward-facing conformation MetNI (IWF/inhibited conformation), 
A299 – A299 between 2 β-sheets (shown in ball-and-stick representations) at the domains’ 
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interface. Binding of L-methionine at the C2 domains stabilizes the A299 – A299 hydrogen 
bond, and consequently locks the MetNI in its inward-facing conformation (PDB: 3TUZ). 
(3) How does the binding protein bind or release its substrate?  
A 42o hinge-type rotation of one lobe of MetQ to the other reorient four aromatic-ring 
residues to form a cage that select for methionine (Fig 4.3). The methionine substrate is 
also stabilized in the binding pocket by making hydrogen bond with the neighboring 
residues, including N229A, at its amino and carboxyl groups (Fig 4.3). 
 
Figure 4.3. Binding of L-methionine substrate by MetQ at an atomic resolution 
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(4) What is the sequential order of interactions among the MetQ binding protein, the 
MetNI transporter, ATP and methionine?  
In the presence of 1mM ATP in the cytoplasm, MetNI is quickly loaded with ATP at a Kd 
~ 33µM. This ATP-loaded MetNI has high affinity (Kd ~ 0.027µM) toward the unliganded 
MetQ (apo MetQ) to form a stable complex. The whole MetNIQ assembly then binds to 
D-met or D-Semet, Kd ~ 6µM.  
 
Figure 4.4. Thermodynamic sequential binding events of the MetNI methionine transport 
system 
(5) What is the mechanistic model for the MetNI methionine transporter? 
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Combining the structural insights with thermodynamic binding constants and 
enzyme kinetic transport activities, we propose a mechanistic model to explain the 
biochemical and structural observations for the methionine transporter. A transport cycle 
starts with a resting- state MetNI that can bind two ATPs and acquire the outward-facing 
conformation MetNI (hypothetical model) (state 2). This hypothetical ATP-bound MetNI 
conformation was modeled based on knowledge of high basal ATPase activity of 
detergent-solubilized MetNI. The ATP-bound MetNI can associate with the apo MetQ to 
form a stable MetNIQ complex (reported here) (state 3). We propose that methionine can 
be loaded into the open translocation pathway. Gating residues, including Y160, F103, and 
M107, may function as a selectivity filter to ensure the right substrate in the cavity. Upon 
ATP hydrolysis, the translocation pathway opens towards the cytoplasm and releases 
methionine inside the cell (state 4). The transporter resets for the next cycle, unless internal 
L-methionine accumulates to a high concentration in the cell. L-methionine molecules then 
bind and lock the C2 domains by stabilizing the A299 –A299 hydrogen bonding networks 
at the C2 domains’ interface, and, in turn, arrest MetNI in its IWF (PDB: 3TUZ) (state 5). 
This mechanistic model can be applied for other Type-I ABC homo-dimeric importers and 
for other ABC transporters subjected to trans-inhibition. 
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Figure 4.5. Proposed mechanistic atomic model of the methionine transporter 
 
 
 
